191 related articles for article (PubMed ID: 12716108)
1. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
[TBL] [Abstract][Full Text] [Related]
2. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
3. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW
Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: implications for kinase function and disease pathogenesis.
Oliveira SM; Ehtisham J; Redwood CS; Ostman-Smith I; Blair EM; Watkins H
J Mol Cell Cardiol; 2003 Oct; 35(10):1251-5. PubMed ID: 14519435
[TBL] [Abstract][Full Text] [Related]
5. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
6. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.
Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG
Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic investigation of pediatric cases of Wolff-Parkinson-White syndrome in Tunisian families.
Nouira S; Ouarda F; Charfeddine C; Arfa I; Ouragini H; Abid F; Abdelhak S
Heart Lung; 2010; 39(5):432-6. PubMed ID: 20561859
[TBL] [Abstract][Full Text] [Related]
11. Wolff-Parkinson-White syndrome: De novo variants and evidence for mutational burden in genes associated with atrial fibrillation.
Coban-Akdemir ZH; Charng WL; Azamian M; Paine IS; Punetha J; Grochowski CM; Gambin T; Valdes SO; Cannon B; Zapata G; Hernandez PP; Jhangiani S; Doddapaneni H; Hu J; Boricha F; Muzny DM; Boerwinkle E; Yang Y; Gibbs RA; Posey JE; Wehrens XHT; Belmont JW; Kim JJ; Miyake CY; Lupski JR; Lalani SR
Am J Med Genet A; 2020 Jun; 182(6):1387-1399. PubMed ID: 32233023
[TBL] [Abstract][Full Text] [Related]
12. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
Gollob MH; Green MS; Tang AS; Gollob T; Karibe A; Ali Hassan AS; Ahmad F; Lozado R; Shah G; Fananapazir L; Bachinski LL; Roberts R
N Engl J Med; 2001 Jun; 344(24):1823-31. PubMed ID: 11407343
[TBL] [Abstract][Full Text] [Related]
13. Cardiac manifestations of PRKAG2 mutation.
Banankhah P; Fishbein GA; Dota A; Ardehali R
BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
Miyamoto L
J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
[TBL] [Abstract][Full Text] [Related]
15. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome.
Zhang LP; Hui B; Gao BR
J Electrocardiol; 2011; 44(4):483-6. PubMed ID: 20381067
[TBL] [Abstract][Full Text] [Related]
16. PRKAG3 polymorphisms associated with sporadic Wolff-Parkinson-White syndrome among a Taiwanese population.
Weng KP; Yuh YS; Huang SH; Hsiao HC; Wu HW; Chien JH; Chen BH; Huang SM; Chien KJ; Ger LP
J Chin Med Assoc; 2016 Dec; 79(12):656-660. PubMed ID: 27866917
[TBL] [Abstract][Full Text] [Related]
17. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish.
Zhang BL; Ye Z; Xu RL; You XH; Qin YW; Wu H; Cao J; Zhang JL; Zheng X; Zhao XX
Clin Genet; 2014 Sep; 86(3):287-91. PubMed ID: 23992123
[TBL] [Abstract][Full Text] [Related]
19. [Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
Hong K; Oliva A; Cheng XS; Brugada P; Brugada J; Sternick EB; Brugada R
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):552-4. PubMed ID: 17711718
[TBL] [Abstract][Full Text] [Related]
20. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
